Ajooni Biotech Limited

NSE: AJOONI · Unclassified

₹2.96-0.34%06 Nov 2026

Ask the data

Instant answers about Ajooni Biotech Limited — computed from its filings, no language model

Market cap₹51 cr

Current price₹2.96

High / Low₹5 / ₹3

P/E12.9

P/B0.56

Book value₹5.3

ROE4.3%

ROCE5.9%

Debt / equity0.19

Dividend yield—

EPS (TTM)₹0.23

Face value₹2

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	51.0	74.0	74.5	80.1	114.7	182.4
EBITDA	1.6	3.1	2.8	2.2	3.7	6.3
Operating margin	3.2%	4.1%	3.7%	2.8%	3.2%	3.4%
Interest	0.6	0.5	0.5	0.6	0.3	0.7
Depreciation	0.6	1.1	1.0	0.9	1.1	2.2
Profit before tax	0.5	1.5	1.6	3.0	4.3	5.7
Tax	0.1	0.4	0.5	0.8	1.0	1.4
Net profit	0.0	1.1	1.1	2.2	3.4	4.3
EPS ₹	0.37	1.05	1.94	0.25	0.20	0.25
Operating cash flow	—	3.7	-5.6	-4.0	-17.7	-5.7
Capex	—	2.1	2.9	5.6	1.1	18.0
Dividend paid	—	0.0	0.0	0.0	0.0	0.0
Total assets	—	—	58,73,144.5	47.5	95.0	120.4
Equity	—	—	41,66,932.6	42.7	88.1	91.2

Quarterly performance

last 21 quarters · ₹ crore

showing latest 8 of 21 periods

	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Revenue	16.2	15.8	18.4	19.3	20.5	10.3	10.6	41.3	21.0	19.5	20.1	19.6	25.7	25.7	34.0	29.3	31.3	31.7	58.8	60.6	63.5
Operating profit	0.3	0.7	1.0	1.0	0.4	0.6	0.5	0.9	0.7	0.6	-0.7	1.6	1.0	0.8	0.9	1.0	0.7	1.5	3.0	1.0	1.7
Operating margin	2.1%	4.5%	5.2%	5.0%	2.1%	5.7%	4.5%	2.3%	3.2%	3.3%	-3.3%	8.1%	3.7%	3.0%	2.7%	3.5%	2.3%	4.7%	5.2%	1.6%	2.6%
Other income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	1.6	0.3	0.0	0.3	0.4	1.3	0.7	0.1	0.3	1.3	0.3
Interest	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.5
Depreciation	0.1	0.2	0.3	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.8	0.9	0.8
Profit before tax	0.1	0.4	0.5	0.6	0.1	0.2	0.1	0.8	0.4	0.5	0.6	1.5	0.6	0.8	1.0	1.9	1.0	1.2	2.4	1.1	0.7
Tax	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.3	-0.0	0.1	0.1	0.6	0.2	0.2	0.3	0.4	0.2	0.3	0.7	0.2	0.2
Net profit	0.0	0.0	0.0	0.0	-0.1	0.2	0.1	0.5	0.4	0.4	0.4	0.9	0.5	0.6	0.7	1.5	0.8	0.9	1.6	0.9	0.4
EPS ₹	0.04	0.31	0.35	0.44	-0.06	0.00	0.06	0.31	0.23	0.23	0.25	0.10	0.03	0.04	0.04	0.09	0.02	0.08	0.10	0.05	0.01
Revenue YoY	—	—	—	—	26.7%	-44.0%	-44.9%	101.2%	—	89.3%	88.6%	-52.5%	22.2%	32.0%	69.7%	49.5%	21.9%	23.4%	72.6%	107.1%	103.0%
Profit YoY	—	—	—	—	—	—	—	—	—	150.0%	300.0%	68.5%	17.5%	55.0%	65.9%	69.2%	66.0%	50.0%	126.0%	-38.3%	-44.9%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 15 periods

	DEC '21	MAR '22	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
ROE	—	—	0.0%	3.6%	4.4%	5.0%	5.2%	2.8%	3.2%	3.8%	4.2%	4.4%	5.5%	4.7%	4.3%
ROCE	—	—	0.0%	5.0%	6.0%	7.9%	8.5%	4.5%	4.9%	5.2%	5.6%	5.6%	7.1%	5.9%	5.9%
Net margin	0.0%	-0.1%	1.5%	1.6%	1.7%	2.7%	2.6%	2.7%	2.6%	2.9%	3.1%	3.2%	3.2%	2.4%	1.8%
EBITDA margin	4.3%	4.2%	3.2%	3.0%	1.6%	2.8%	3.0%	2.9%	4.0%	3.2%	2.8%	3.3%	4.1%	3.4%	3.4%
Debt / equity	—	—	0.12	0.19	0.19	0.05	0.05	0.03	0.03	0.02	0.02	0.10	0.10	0.19	0.19
Interest coverage	3.52	3.70	4.04	4.28	5.18	6.44	6.67	8.95	11.08	13.76	18.56	14.63	14.33	8.97	5.79
Asset turnover	—	—	0.00	1.59	1.76	1.69	1.78	1.02	1.18	1.21	1.27	1.21	1.45	1.52	1.78

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 8 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	10,00,558.2	17,52,274.4	17.5	17.5	34.5	34.5	34.5	34.5
Other equity / reserves	6,85,419.0	24,14,658.1	23.2	25.2	51.7	53.6	55.3	56.7
Total equity	16,85,977.2	41,66,932.6	40.7	42.7	86.1	88.1	89.8	91.2
Borrowings	6,71,789.6	5,17,693.4	7.9	2.2	2.2	1.9	8.9	17.8
Current liabilities	8,18,420.3	15,20,943.7	15.6	3.0	0.7	4.8	5.2	27.4
Non-current liabilities	2,36,390.4	1,85,268.1	1.7	1.8	2.3	2.1	9.1	1.8
Total assets	27,40,787.9	58,73,144.5	58.0	47.5	89.1	95.0	104.1	120.4
Property, plant & equipment	6,75,642.4	6,28,911.5	6.1	10.3	9.9	10.9	11.0	25.9
Capital work-in-progress	—	26,185.0	0.8	0.9	1.1	0.3	11.5	0.0
Investments	95,906.9	3,73,721.9	1.1	2.1	4.3	3.5	3.4	2.5
Inventories	4,47,665.9	6,99,396.1	10.2	15.4	17.0	24.0	23.3	39.5
Receivables	13,28,747.5	20,55,109.2	21.8	13.0	23.3	16.2	15.8	17.8
Cash & equivalents	18,238.8	30,934.0	0.3	0.4	17.0	6.8	15.3	0.4

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	3.7	-5.6	-4.0	-17.7	-5.7
Cash from investing	-1.9	-15.8	7.6	-17.1	-15.8
Cash from financing	-2.0	21.7	-3.6	24.8	15.1
Capex	2.1	2.9	5.6	1.1	18.0
Free cash flow	1.6	-8.4	-9.6	-18.8	-23.8
Dividends paid	0.0	0.0	0.0	0.0	0.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹25.9 cr21%

Investments

₹2.5 cr2%

Inventories

₹39.5 cr33%

Receivables

₹17.8 cr15%

Cash & equivalents

₹0.4 cr0%

Other assets

₹34.4 cr29%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Ajooni Biotech Limited	51	2.96	12.9	0.56	4.3%

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-1.7%

6 months-31.2%

1 year-43.1%

3Y CAGR-14.9%

5Y CAGR-25.3%

10Y CAGR—

50-day avg₹3.21

200-day avg₹3.90

RSI (14)45

FAQs

What is the share price of Ajooni Biotech Limited?

Ajooni Biotech Limited (AJOONI) closed at ₹2.96 on NSE on 06 Nov 2026.

What is the market cap of Ajooni Biotech Limited?

₹51 crore at the latest close.

What is the P/E ratio of Ajooni Biotech Limited?

12.9, on trailing-twelve-month earnings from its filings.

How fast is Ajooni Biotech Limited growing?

Ajooni Biotech Limited: revenue has compounded at 34.8% a year over three years; net profit at 56.8% a year. Latest-quarter revenue is up 103.0% year on year, profit down 44.9%.

How profitable is Ajooni Biotech Limited?

On a trailing-twelve-month basis return on equity is 4.3%, return on capital employed 5.9%, operating margin 3.4%, net margin 1.8%.

How much debt does Ajooni Biotech Limited have?

Ajooni Biotech Limited is lightly geared: debt to equity is 0.19 with borrowings of ₹18 cr against cash of ₹0 cr (balance sheet of 2026-03-31). Operating profit covers interest 5.8 times.

Financials parsed from Ajooni Biotech Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from MAR '21, annual from FY21, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.